HIGHLIGHTS
- who: Kathleen Ducoin and collaborators from the INCIT, UMR, EMR6001, France have published the research work: Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of 29/08/2022
- what: The aim of this study was to simultaneously analyze, using flow cytometry, the relative ex vivo expression of five major ICs, namely PD-1, TIGIT, Tim-3, Lag3 and NKG2A, by the CD3+ TILs of CRCs, as well as that of their ligands by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.